¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Phosphofructokinase-1, Muscle Type"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • geniohyoid muscle
    Åγ¡¸ñ»Ô±Ù, À̼³°ñ±Ù
  • gluteus maximus muscle
    Å«º¼±â±Ù, ´ëµÐ±Ù
  • gluteus muscle
    º¼±â±Ù, µÐ±Ù
  • gracilis muscle
    µÎµ¢Á¤°­±Ù, ¹Ú±Ù
  • heart muscle disease
    ½ÉÀå±ÙÀ°º´, ½É±ÙÁúȯ
  • helicis muscle
    ±ÍµÑ·¹±Ù, ÀÌ·û±Ù
  • hamstring muscle flap
    ³Ò´Ù¸®µÚ±Ù(À°)ÆÇ, ³ÐÀû´Ù¸®µÚ±Ù(À°)ÆÇ
  • iliacus muscle
    ¾ûµ¢±Ù, Àå±Ù
  • iliococcygeus muscle
    ¾ûµ¢²¿¸®±Ù, Àå¹Ì°ñ±Ù
  • iliocostalis muscle
    ¾ûµ¢°¥ºñ±Ù, Àå´Á±Ù
  • involuntary muscle
    ºÒ¼öÀDZÙ, Á¦´ë·Î±Ù
  • iliopsoas muscle
    ¾ûµ¢Ç㸮±Ù, Àå¿ä±Ù
  • ischiocavernous muscle
    ±ÃµÕÇØ¸éü±Ù, Á°ñÇØ¸éü±Ù
  • infrahyoid muscle
    ¸ñ»Ô¾Æ·¡±ÙÀ°, ¼³°ñÇϱÙ
  • infraspinatus muscle
    °¡½Ã¾Æ·¡±Ù, ±ØÇϱÙ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • extraocular muscle
    (¢¡ocular muscle) ¹Ù±ù´«±ÙÀ°, ¾È±¸±ÙÀ°
  • facial muscle
    ¾ó±¼±ÙÀ°
  • flexor carpi ulnaris muscle
    ÀÚÂʼոñ±ÁÈû±Ù
  • flexor digiti minimi brevis muscle
    ªÀº»õ³¢±ÁÈû±Ù
  • flexor digitorum brevis muscle
    ªÀº¹ß°¡¶ô±ÁÈû±Ù
  • flexor digitorum longus muscle
    ±ä¹ß°¡¶ô±ÁÈû±Ù
  • flexor digitorum profundus muscle
    ±íÀº¼Õ°¡¶ô±ÁÈû±Ù
  • flexor digitorum superficialis muscle
    ¾èÀº¼Õ°¡¶ô±ÁÈû±Ù
  • flexor hallucis brevis muscle
    ªÀº¾öÁö±ÁÈû±Ù
  • flexor hallucis longus muscle
    ±ä¾öÁö±ÁÈû±Ù
  • flexor pollicis brevis muscle
    ªÀº¾öÁö±ÁÈû±Ù
  • flexor pollicis longus muscle
    ±ä¾öÁö±ÁÈû±Ù
  • fusiform muscle
    ¹æÃß±ÙÀ°
  • hamstring muscle flap
    ³Ò´Ù¸®µÚ±ÙÀ°ÆÇ
  • intrafusal muscle fiber
    ¹æÃß¼Ó±ÙÀ°¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • antitragus muscle
    ¸Â±¸½½±Ù
  • appendicular muscle
    »çÁö ±Ù(ÞÌò¶ÐÉ), ºÎ¼Ó±â°ü ±Ù(ݾáÕÐïίÐÉ), ºÎ¼Ó±â ±Ù(ݾáÕÐïÐÉ).
  • arrector pili muscle
    Åм¼¿ò±Ù
  • articular muscle
    °üÀý ±Ù(¡­ÐÉ).
  • aryepiglottic muscle
    ¸ð»ÔÈĵε¤°³±Ù
  • aryepiglottic muscle =musculus aryepiglotticus <
    ÇÇ¿­Èĵΰ³±Ù
  • frontal muscle
    ÀüµÎ±Ù(îñÔéÐÉ).
  • fusiform muscle
    ¹æÃß±ÙÀ°
  • fusiform musculus ; muscle fusiformis
    °¡¶ô¸ð¾ç±Ù, ¹æÃß»ó±Ù(Û·õßßÒÐÉ).
  • gastrocnemial muscle<³ª> musculus gastrocnemius
    Àå´ÜÁö±Ù, ºñ º¹±Ù(ÛÉÜÙÐÉ).
  • gastrocnemial muscle<³ª> musculus gastrocnemius
    Àå´ÜÁö±Ù, ºñº¹±Ù(ÛÉÜÙÐÉ).
  • genioglossal muscle
    Åγ¡Çô±Ù, À̼³±Ù( àßÐÉ).
  • genioglossal muscle
    À̼³±Ù, Åγ¡Çô±Ù{ÇØ}
  • geniohyoid muscle
    Åγ¡¸ñ»Ô±Ù
  • geniohyoid muscle =musculus geniohyoideus <³ª>
    À̼³°ñ±Ù, Åγ¡¼³°ñ±Ù{ÇØ}
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • blood type
    Ç÷¾×Çü(úìäûúþ)
  • body type
    üÇü
  • body type
    üÇü(ô÷úþ).
  • bubble type vaporizer
    ±âÆ÷Çü ±âÈ­±â
  • calcified hypertrophic type
    ¼®È¸È­ºñ´ëÇü
  • catatonic type
    ±äÀåÇü
  • cellular type dermatofibroma
    ¼¼Æ÷Çü ÇǺμ¶À¯Á¾
  • chief cell type i glomus cell
    °ú¸³¼¼Æ÷
  • cryptogenic type
    ÀáÀçÇü(ËöËøÌ´).
  • cryptogenic type
    ÀáÀçÇü(íÖî¤úþ).
  • crystal type
    °áÁ¤Çü
  • culture, type
    Ç¥ÁرÕÁÖ, ±âÁØÁÖ
  • cyclicodevelopmental type
    ÁÖ±âÀû ¹ßÀ°Çü(ÊÙËÑËôÌ´).
  • cyclicopropagative type
    ÁÖ±âÀû Áõ½ÄÇü(ÊÙÌ¡ËàÌ´).
  • delayed type hypersensitivity
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • Superior pharyngeal constrictor muscle
    À§ÀεμöÃà±Ù
    [¿¾ ¿ë¾î] »óÀεμöÃà±Ù
  • Dartos muscle
    À½³¶±Ù
    [¿¾ ¿ë¾î] À½³¶±Ù
  • Tensor velli palatini muscle
    ÀÔõÀå±äÀå±Ù
    [¿¾ ¿ë¾î] ±¸°³¹üÀå±Ù
  • Middle pharyngeal constrictor muscle
    Áß°£ÀεμöÃà±Ù
    [¿¾ ¿ë¾î] ÁßÀεμöÃà±Ù
  • Erector spinae muscle
    ôÁÖ¼¼¿ò±Ù
    [¿¾ ¿ë¾î] ôÁֱ⸳±Ù
  • Helicis major muscle
    Å«±ÍµÑ·¹±Ù
    [¿¾ ¿ë¾î] ´ëÀÌ·û±Ù
  • Arrector pili muscle
    Åм¼¿ò±Ù
    [¿¾ ¿ë¾î] ÀÔ¸ð±Ù(í¡Ù¾ÐÉ)
  • Cutaneous muscle
    ÇǺαÙÀ°
    [¿¾ ¿ë¾î] ÇDZÙ
  • Levator ani muscle
    Ç×¹®¿Ã¸²±Ù
    [¿¾ ¿ë¾î] Ç×¹®°Å±Ù
  • Unisegmental muscle
    ȬºÐÀý±ÙÀ°
    [¿¾ ¿ë¾î] ´ÜºÐÀý±Ù
  • Dilator muscle
    È®´ë±ÙÀ°
    [¿¾ ¿ë¾î] »ê´ë±Ù
  • Rectouterine muscle
    °ðâÀÚÀڱñÙ
    [¿¾ ¿ë¾î] Á÷ÀåÀڱñÙ
  • Pyloric sphincter muscle
    ³¯¹®Á¶ÀÓ±Ù
    [¿¾ ¿ë¾î] À¯¹®°ý¾à±Ù
  • Bulbospongiosus muscle
    ¸Á¿ïÇØ¸éü±Ù
    [¿¾ ¿ë¾î] ±¸Çظéü±Ù
  • Smooth muscle cell
    ¹Î¹«´Ì±ÙÀ°¼¼Æ÷
    [¿¾ ¿ë¾î] ÆòȰ±Ù±Ù¼¼Æ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
APCKD adult-type polycystic kidney disease
ATCC American Type Culture Collection
ATD Alzheimer-type dementia; androstatrienedione; anthropomorphic test dummy; antithyroid drug; aqueous ...
beta [Greek letter beta] an anomer of a carbohydrate; buffer capacity; carbon separated from a carboxyl by one other carbon i...
BHK baby hamster kidney [cells]; type-B Hong Kong [influenza virus]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
MRF muscle regulatory factor
MAP muscle action potential
MBF Muscle blood flow
MCH Muscle contraction headaches
MCK Muscle creatine kinase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • congenital and developmental muscle disorder
    ¼±Ãµ¼º ¹× ¹ßÀ°¼º ±ÙÀå¾Ö
    Ãâ»ý ½ÃºÎÅÍ ±ÙÀúÇϸ¦ ³ªÅ¸³»°í Èå´ÃÈå´ÃÇÑ ¾ÆÀÌ. flo
  • congenital muscle disorder
    ¼±Ãµ¼º ±Ù Àå¾Ö
  • corrugator supercilii muscle
    ´«½ç ÁÖ¸§±Ù, Ã߹̱Ù
    À̸¶¿¡ ¼¼·ÎÀÇ ÁÖ¸§À» Áþ°Ô Çϸç, ´«½ÒÀ» ÂîǪ¸®´Âµ¥ °ü¿©ÇÑ´Ù.
  • cremasteric muscle spasm
    °Å°í±Ù °æ·Ã
  • cricoarytenoid muscle
    À±»ó ÇÇ¿­±Ù
  • cricopharyngeus muscle
    À±»ó ÀεαÙ
  • cricothyroid muscle
    À±»ó °©»ó±Ù, ȯ»ó °©»ó±Ù
    ȯ»ó ¿¬°ñ Àü¸é¿¡¼­ ½ÃÀÛÇÏ¿© °©»ó ¿¬°ñ ÇÏ¿¬¿¡ ºÎÂøÇϸç, ÀÌ ±ÙÀ°ÀÌ ¼öÃàÇÏ¸é °©»ó ¿¬°ñÀ» ÀüÇϹæÀ¸·Î ȸÀü½ÃÄÑ ¼º´ëÀÇ ±äÀåµµ¸¦ Áõ°¡½ÃŲ´Ù.
  • delayed-onset muscle soreness
    Áö¿¬¼º ±ÙÅëÁõ
    °£ÇæÀûÀÎ °ú»ç¿ë
  • deltoid muscle
    »ï°¢±Ù
    1. »ó¿ÏÀ» ¸ðµç ¹æÇâÀ¸·Î ¿òÁ÷ÀÌ°Ô ÇÏ´Â ±ÙÀ° ±ºÀÇ Çϳª. ¾î±úÀÇ °î¼±À» ¸¸µé°í ÀÖ´Â °ÍÀº ´ëºÎºÐ ÀÌ ±ÙÀ°ÀÌ´Ù. ¼â°ñ ¹Ù±ùÂÊÀÇ 1/3, °ßºÀ, °ß°©°ñÀÇ ÇÏ¿¬, ±ØÇϱٸ·¿¡¼­ ½ÃÀÛµÇ¾î »ó¿Ï°ñÀÇ ¹Ù±ùÂÊ¿¡¼­ Áß¾Óº¸´Ù ´Ù¼Ò À­ ºÎºÐ¿¡ ºÎÂøµÇ¾î ÀÖ´Ù. »ï°¢±ÙÀÇ ÀüÃø¿¬¿¡´Â ´ëÈä±Ù°úÀÇ °æ°è°¡ µÇ´Â ´ëÈä±Ù±¸°¡ ÀÖ´Ù. ÀÌ ±ÙÀº ÀüºÎ, ÁߺÎ, Èĺο¡¼­ÀÇ ÀÛ¿ëÀÌ °¢±â ´Þ¶ó, Áߺδ »ó¿ÏÀ» ¼öÆòÀ¸·Î µé°í, ÀüºÎ´Â Àü¹æÀ¸·Î, Èĺδ ÈĹæÀ¸·Î Àâ¾Æ´ç±ä´Ù. 2. ¾î±úÁ×Áö¿¡ ÀÖ´Â ±ÙÀ¸·Î ¼â°ñÀÇ ¹Ù±ùºÎ¿Í °ß°©°ñÀÇ ¹èÃø¸é¿¡ ÀÖ´Â °ß°©±Ø°ú °ßºÀ¿¡¼­ ÀϾ ¹Ù±ùÂÊÀ¸·Î »¸¾î¼­ »ó¿Ï°ñ Áß¾ÓÀÇ ¿Ü¿¬¿¡ ºÙ¾ú´Ù. ¾×¿Í ½Å°æÀ¸·Î Áö¹èµÇ¾î »óÁöÀÇ Àü¹æ, ÈÄ¹æ ¹× Ãø¹æÀ¸·Î µé¾î¿Ã¸®´Â ÁÖ µ¿ÀÛ±ÙÀÇ Çϳª´Ù.
  • depressor labii inferioris muscle
    ¾Æ·¡ ÀÔ¼ú ³»¸²±Ù, Çϼø ÇÏü±Ù
    ÀÛ°í, 4°¢ÇüÀÎ ±ÙÀ°À¸·Î mental formen ÀüÇÏ ºÎÀ§¿¡¼­ ±â½ÃÇÏ¿© ¾Æ·¡ ÀÔ¼úÀÇ ÇǺο¡ Á¤ÁöÇÑ´Ù.
  • depressor septi muscle
    ÄÚ Áß°Ý ³»¸²±Ù, ºñÁß°Ý ÇÏü±Ù
    »ó¾ÇÀÇ ÁßÀýÄ¡ ºÎÀ§¿¡¼­ ±â½ÃÇÏ¿© nasal se
  • diatal muscle
    ¿øÀ§ ±ÙÀ°, ¿øÀ§±Ù
  • digastric muscle
    ¾ÇÀ̺¹±Ù
  • dilator muscle
    È®´ë±Ù, È®Àå±Ù, »ê´ë±Ù
  • dilator naris muscle
    ºñÀÍ È®´ë±Ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
deoxyribonucleases, type III site-specific <enzyme> Enzyme systems composed of two subunits and requiring ATP and magnesium for endonucleolytic activity; they do not function as atpases. They exist as complexes with modification methylases of similar specificity.
The systems recognise specific short DNA sequences and cleave a short distance, about 24 to 27 bases, away from the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers.
Registry number: EC 3.1.21.5
(12 Dec 1998)
deoxyribonucleases, type II site-specific <enzyme> Enzyme systems containing a single subunit and requiring only magnesium for endonucleolytic activity. The corresponding modification methylases are separate enzymes. The systems recognise specific short DNA sequences and cleave either within, or at a short specific distance from, the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers.
Registry number: EC 3.1.21.4
(12 Dec 1998)
deoxyribonucleases, type I site-specific <enzyme> Enzyme systems containing three different subunits and requiring ATP, s-adenosylmethionine, and magnesium for endonucleolytic activity to give random double-stranded fragments with terminal 5'-phosphates. They function also as DNA-dependent atpases and modification methylases, catalyzing the reactions of EC 2.1.1.72 and EC 2.1.1.73 with similar site-specificity. The systems recognise specific short DNA sequences and cleave at sites remote from the recognition sequence. Enzymes from different microorganisms with the same specificity are called isoschizomers.
Registry number: EC 3.1.21.3
(12 Dec 1998)
diabetes, type 1 Insulin dependent diabetes or juvenile diabetes.
(12 Dec 1998)
diabetes, type 2 Non-insulin dependent diabetes, adult-onset diabetes or insulin-resistant diabetes.
(12 Dec 1998)
disease, gaucher's type 1 A progressive genetic disease caused by a defect in an enzyme. The enzyme, called glucocerebrosidase, is needed to break down the chemical glucocerebroside. The enzyme defect in persons with Gaucher's disease (GD) leads to the accumulation of glucocerebroside in the spleen, liver, and lymph nodes. The most common early sign is enlargement of the spleen (located in the upper left abdomen). Other signs include low red blood cell counts (anaemia), a decrease in blood clotting cells (platelets), increased pigmentation of the skin, and a yellow fatty spot on the white of the eye (a pinguecula). Severe bone involvement can lead to pain and collapse of the bone of the hips, shoulders, and spine. The GD gene is on chromosome 1. The disease is a recessive trait. Both parents carry a GD gene and transmit it for their child with the disease. The parents' risk of a child with the disease is 1 in 4 with each pregnancy. This type of Gaucher's disease (noncerebral juvenile Gaucher's disease) is most common in Ashkenazi Jews (of European origin) and is the most common genetic disease among Jews in the United States.
(12 Dec 1998)
immunization, haemophilus influenzae type b See immunization, hib.
(12 Dec 1998)
influenza type a A common acute viral infection of the nasopharynx and respiratory tract which occurs in epidemic forms. A common cause is the Influenza a virus. Annual vaccination is recommended for those in high risk groups (health care workers, elderly and immunocompromised) for influenza infection.
Common symptoms include runny nose, fever, weakness, headache, body aches, muscle aches, nausea and back pain. Treatment of symptoms has been successful with amantadine or rimantadine.
(27 Sep 1997)
interferon type I <chemical> Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (interferon-alpha and interferon-beta).
Pharmacological action: antineoplastic agent, antiviral agents.
(12 Dec 1998)
interferon type II <chemical> The major interferon produced by mitogenically or antigenically stimulated lymphocytes. It is structurally different from type I interferon (interferon type I) and its major activity is immunoregulation. It has been implicated in the expression of class II histocompatibility antigens in cells that do not normally produce them, leading to autoimmune disease.
Pharmacological action: antineoplastic agent, antiviral agents.
Chemical name: Interferon-gamma (human lymphocyte protein moiety reduced)
(12 Dec 1998)
ocean-type fish An anadromous fish that shows no indication on its scales or other hard parts of an extended freshwater residence early in its life.
(09 Oct 1997)
Ellis type 1 glomerulonephritis An obsolete designation for glomerulonephritis presenting as acute glomerulonephritis, followed by complete recovery in most cases, or the development of rapidly progressive glomerulonephritis, or incomplete remission with persistent proteinuria and subsequent development of chronic glomerulonephritis.
Synonym: Ellis type 1 nephritis.
(05 Mar 2000)
Ellis type 1 nephritis An obsolete designation for glomerulonephritis presenting as acute glomerulonephritis, followed by complete recovery in most cases, or the development of rapidly progressive glomerulonephritis, or incomplete remission with persistent proteinuria and subsequent development of chronic glomerulonephritis.
Synonym: Ellis type 1 nephritis.
(05 Mar 2000)
Ellis type 2 glomerulonephritis An obsolete designation for glomerulonephritis which is usually not related to preceding bacterial infection; characterised by an insidious onset of the nephrotic syndrome, failure of complete remission, and eventual development of chronic renal failure. The kidneys usually show membranous glomerulonephritis.
Synonym: Ellis type 2 nephritis.
(05 Mar 2000)
Ellis type 2 nephritis An obsolete designation for glomerulonephritis which is usually not related to preceding bacterial infection; characterised by an insidious onset of the nephrotic syndrome, failure of complete remission, and eventual development of chronic renal failure. The kidneys usually show membranous glomerulonephritis.
Synonym: Ellis type 2 nephritis.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á